Literature DB >> 4810999

Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters.

R C Dutton, L H Edmunds, J C Hutchinson, B B Roe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4810999

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  The effect of temperature and shear rate on platelet aggregation.

Authors:  A P Shortland; N P Rhodes; A Rattray; R A Black; D F Williams
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  Cerebral blood flow during cardiopulmonary bypass in man: effect of arterial filtration.

Authors:  L Henriksen; E Hjelms
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

3.  Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue.

Authors:  W Martin; T Spyt; I Thomas; J F Davidson; D J Wheatley
Journal:  Eur J Nucl Med       Date:  1989

4.  The cerebral complications of coronary artery bypass surgery.

Authors:  P L Smith
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

5.  A new bubble oxygenator (OCVC oxygenator): development and clinical application.

Authors:  T Tamiya; T Nishizawa; H Horibe; K Koja; I Suzuki; K Shiramatsu; S Ito
Journal:  Jpn J Surg       Date:  1978-12

Review 6.  Perioperative stroke. Part II: Cardiac surgery and cardiogenic embolic stroke.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

7.  Transitory cerebral microvascular blockade after cardiopulmonary bypass.

Authors:  R H Patterson; L Rosenfeld; R S Porro
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

8.  Influence of Sulfation on Platelet Aggregation and Activation with Differentially Sulfated Hyaluronic Acids.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.